Will you have Jaundice hepatocellular with Pseudomyxoma peritonei - from FDA reports


There is no Jaundice Hepatocellular reported by people with Pseudomyxoma Peritonei yet. We study people who have Jaundice Hepatocellular and Pseudomyxoma Peritonei from FDA. Find out below who they are, other conditions they have and drugs they take.

What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on Jaundice hepatocellular and Pseudomyxoma peritonei, and their synonyms.

What is Pseudomyxoma peritonei?

Pseudomyxoma peritonei (uncommon tumour known for its production of mucus in the abdominal cavity) (latest reports from 129 Pseudomyxoma peritonei patients)

What is Jaundice hepatocellular?

Jaundice hepatocellular (cell necrosis reduces the liver's ability to metabolize and excrete bilirubin leading to a build up of unconjugated bilirubin in the blood) has been reported by people with high blood pressure, coronary arterial stent insertion, burkitt lymphoma, sepsis, hiv infection (latest reports from 125 Jaundice hepatocellular patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.

On Mar, 23, 2019

No report is found.

Do you have Jaundice hepatocellular with Pseudomyxoma peritonei?

You are not alone:

Related studies

Drugs that are associated with Jaundice hepatocellular
Jaundice hepatocellular (144 drugs)
Other conditions that could cause Jaundice hepatocellular
Jaundice hepatocellular (134 conditions)
Browse all symptoms of Pseudomyxoma peritonei
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you have Jaundice hepatocellular and Pseudomyxoma peritonei

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.